SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'AB0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1H8S_A_AICA1000_1 (MUTANT AL2 6E7P9G)	2e27	ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN (Mus musculus)	6 / 12	TYR L 36 PHE L 98 TRP H 33 VAL H 37 ALA H 93 TRP H 103	None None AB0 H6001 (-3.7A) None None None	0.80A	1h8sA-2e27L: 20.6	1h8sA-2e27L: 26.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1I7Z_A_COCA301_1 (CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION)	2e27	ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN (Mus musculus)	4 / 8	TYR L 36 TYR L 49 LEU L 89 TRP L 96	None AB0 H6001 (-4.6A) None AB0 H6001 (-4.2A)	0.67A	1i7zA-2e27L: 21.0	1i7zA-2e27L: 31.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JGL_L_ESTL911_1 (IG GAMMA-1-CHAIN IG KAPPA-CHAIN)	2e27	ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN (Mus musculus)	5 / 10	GLY H1002 ALA L 34 TYR L 36 LEU L 46 TYR L 49	None AB0 H6001 ( 4.0A) None AB0 H6001 ( 4.9A) AB0 H6001 (-4.6A)	0.57A	1jglH-2e27H: 19.9 1jglL-2e27H: 16.2	1jglH-2e27H: 27.98 1jglL-2e27H: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OTH_A_IMNA301_1 (PHOSPHOLIPASE A2 VRV-PL-VIIIA)	2e27	ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN (Mus musculus)	3 / 3	ASP H 100 TYR L 49 LYS L 55	None AB0 H6001 (-4.6A) None	1.22A	2othA-2e27H: undetectable	2othA-2e27H: 20.00

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1H8S_A_AICA1000_1","MUTANT AL2 6E7P9G","2e27","ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN;ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN","Mus musculus",6,"TYR L  36;PHE L  98;TRP H  33;VAL H  37;ALA H  93;TRP H 103","None;None;AB0 H6001 (-3.7A);None;None;None","0.80A","1h8sA-2e27L:20.6",null],["1I7Z_A_COCA301_1","CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION","2e27","ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN","Mus musculus",4,"TYR L  36;TYR L  49;LEU L  89;TRP L  96","None;AB0 H6001 (-4.6A);None;AB0 H6001 (-4.2A)","0.67A","1i7zA-2e27L:21.0","1h8sA-2e27L:26.59"],["1JGL_L_ESTL911_1","IG GAMMA-1-CHAIN;IG KAPPA-CHAIN","2e27","ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN;ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN","Mus musculus",5,"GLY H1002;ALA L  34;TYR L  36;LEU L  46;TYR L  49","None;AB0 H6001 ( 4.0A);None;AB0 H6001 ( 4.9A);AB0 H6001 (-4.6A)","0.57A","1jglH-2e27H:19.9;1jglL-2e27H:16.2","1i7zA-2e27L:31.05"],["2OTH_A_IMNA301_1","PHOSPHOLIPASE A2 VRV-PL-VIIIA","2e27","ANTI-CIGUATOXIN ANTIBODY, HEAVY CHAIN;ANTI-CIGUATOXIN ANTIBODY, LIGHT CHAIN","Mus musculus",3,"ASP H 100;TYR L  49;LYS L  55","None;AB0 H6001 (-4.6A);None","1.22A","2othA-2e27H:undetectable","1jglH-2e27H:27.98;1jglL-2e27H:22.22"]]